Ondansetron: Indications and Applications in the Paediatric Intensive Care Unit

Brittain R.T. , Butler A. , Coates I.H. GR38032F, a novel selective 5HT₃ receptor antagonist. Br J Pharmacol 1987; 90: 87.

Hesketh P.J. , Murphy W.K. , Lester E.P. GR38032F (GR-C507/74): a novel compound effective in the prevention of acute cisplatin-induced emesis. J Clin Onc 1989; 7: 700–705.

Priestman T.J. Clinical studies with ondansetron in the control of radiation induced emesis. Eur J Cancer Clin Onc 1989; 25(Suppl 1): 529–533.

Buck M.L. , Blumer J.L. Opioids and other analgesics: Adverse effects in the intensive care unit. Crit Care Clinics 1991; 7: 615–637.

Smilkstein M.J. , Bronstein A.C. , Linden C. , Augenstein W.L. , Kulig K.W. , Rumack B.H. Acetaminophen overdose: A 48 hour intravenous N-acetylcysteine treatment protocol. Ann Amerg Med 1991; 20: 1058–1063.

Cubeddu L.X. , Hoffman I.S. , Fuenmayor N.T. , Finn A.L. Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide containing chemotherapy regimens. J Clin Onc 1990; 8: 1721–1727.